• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGabather AB
    Picture of Gabather AB logo

    GABA — Gabather AB Share News

    SEK0.020.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    • Market Cap
      SEK14.41m
    • Enterprise Value
      SEK10.72m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GABA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GABA Dividends
    • Brief: Gabather Raises SEK 26.5 Million In Rights Issue

      12/12/2017 07:26
    • Brief: Gabather Q3 pretax loss at SEK 1.8 million

      13/11/2017 07:03
    • Brief: Gabather proposes rights issue of SEK 33.1 million

      26/10/2017 08:41
    • Brief: Gabather receives patent in India for l1001c triazoloderivat

      03/10/2017 07:57
    • Brief: Gabather files patent application for drug candidate GT-002

      03/05/2017 10:08
    • Brief: Gabather signs deal with Mercachem for production of GT-002 substance

      02/05/2017 06:52
    • Brief: Gabather updates on patent in India

      16/03/2017 10:32
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.